Your session is about to expire
← Back to Search
GVAX for Colorectal Cancer
Study Summary
This trial is a study to see if it is safe to give a vaccine made from a person's own colorectal cancer cells. The study will also look at if the vaccine has any effect, good or bad, on the cancer returning after the person has surgery to remove the cancer from their liver.
- Colorectal Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 1 & 2 trial • 29 Patients • NCT01696877Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is recruitment still underway for this trial?
"Affirmative. According to the clinicaltrials.gov website, this research is actively recruiting participants as of now. This project was initially posted on July 1st 2013 and its details were last amended on January 4th 2018; 15 individuals are being sought after by one location for enrolment in the trial."
What potential risks has GVAX been known to pose for individuals?
"GVAX's safety rating is 1 given that this Phase 1 trial has limited data regarding its effectiveness and security."
To what extent has the populace participated in this experiment?
"Affirmative. Clinicaltrials.gov displays that this medical research is presently looking for participants, having been initially advertised on the 1st of July 2013 and last modified on 4th January 2018. 15 subjects are required between a single site."
Share this study with friends
Copy Link
Messenger